ASP Isotopes Inc. Common Stock

NASDAQ ASPI

Data sourced from iex and EODHD
Download Data

ASP Isotopes Inc. Common Stock EBIT to Total Assets Ratio 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending March 31, 2024: 1.38%

ASP Isotopes Inc. Common Stock EBIT to Total Assets Ratio 1 year YoY Change (%) is 1.38% for the Trailing 12 Months (TTM) ending March 31, 2024. The EBIT to Total Assets Ratio measures a company's operating earnings (EBIT) generated per dollar of total assets. It shows how efficiently a company utilizes its assets to generate earnings. A higher ratio indicates better asset utilization and profitability. It reflects the ability of a company to generate earnings from its invested assets and is useful in assessing operational efficiency and financial performance. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • ASP Isotopes Inc. Common Stock EBIT to Total Assets Ratio for the Trailing 12 Months (TTM) ending December 31, 2022 was -0.14.
NASDAQ: ASPI

ASP Isotopes Inc. Common Stock

CEO Mr. Paul Elliot Mann
IPO Date Nov. 10, 2022
Location United States
Headquarters 433 Plaza Real, Boca Raton, FL, United States, 33432
Employees 76
Sector Basic Materials
Industry Chemicals
Description

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

StockViz Staff

September 20, 2024

Any question? Send us an email